<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0245">
 <label>49</label>
 <element-citation publication-type="journal" id="rf0225">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Curth</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Drosten</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sauerhering</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Becker</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rox</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hilgenfeld</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved Î±-ketoamide inhibitors</article-title>
  <source>Science</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1126/science.abb3405</pub-id>
 </element-citation>
</ref>
